Endoscopic submucosal dissection (ESD) has been widely implemented for the treatment of gastric superficial neoplasia. However, the final pathologic diagnosis after ESD may be different from that indicated by the results of endoscopic forceps biopsy. This study identified risk factors for gastric epithelial lesions so that early gastric cancer (EGC) could be diagnosed after ESD.
Introduction
Gastric cancer is the most common gastrointestinal malignancy in East Asia, including South Korea. In South Korea, the National Cancer Screening Program recommends biennial gastric endoscopic or radiologic contrast examinations and gastric cancer screening for people >40 years. [1] Increasing endoscopic screening for the general population leads to increased detected cases of early gastric cancer (EGC) and premalignant gastric superficial neoplasms such as adenomas (low-grade dysplasia or high-grade dysplasia). The proportion of EGC cases among gastric cancers has increased to 57.6% in South Korea. [2] Endoscopic submucosal dissection (ESD) is useful for the treatment of EGC or gastric adenomas because of the higher en bloc resection rate compared with conventional endoscopic mucosal resection using a snare, regardless of the lesion size. [3] Recently, ESD has been approved as a treatment modality for EGC without the risk of lymph node metastasis. [4, 5] Overall survival rates associated with ESD and surgical resection for EGC were similar to those for EGC determined by absolute and expanded indications. [6] According to the Correa hypothesis, the intestinal type of gastric cancer develops from precursor lesions such as atrophic gastritis, intestinal metaplasia, and adenomas (low-grade dysplasia/high-grade dysplasia). [7] According to the revised Vienna classification, gastric epithelial neoplasia can be divided into 5 groups: category 1, negative for neoplasia; category 2, indefinite for neoplasia; category 3, mucosal low-grade neoplasia; category 4, mucosal high-grade dysplasia; and category 5, invasive carcinoma. [8] Curative resection by endoscopic or surgical maneuvers should be recommended for category 4 or category 5; however, the recommended treatment plans for category 2 and category 3 are ambiguous and include regular follow-up or endoscopic resection. An endoscopic forceps biopsy for suspected EGC or premalignant lesions is a simple diagnostic tool. However, the pathologic results of endoscopic forceps biopsy used for tissues and resected specimens may be different. The reported discrepancy rates were 20% to 76% and were highly associated with pathologic grading of tissues examined by endoscopic forceps biopsy. [9] [10] [11] To treat gastric superficial neoplasia such as gastric adenomas, it is important to know the endoscopic features associated with EGC. The aim of this study was to identify factors associated with upstaged diagnoses of EGC after ESD for category 2 to 4 lesions (indefinite for neoplasia, low-grade neoplasia, or high-grade dysplasia) after endoscopic forceps biopsy.
Materials and methods

Patients
From December 2008 to January 2017, the medical records of patients who underwent ESD at the Pusan National University Yangsan Hospital in South Korea were retrospectively reviewed. During the study period, a total of 2011 gastric lesions were removed by ESD. Among these, 443 lesions were diagnosed as gastric cancer before ESD and 27 gastric subepithelial tumors were excluded. Ultimately, the data of 1541 lesions (contributed by 1410 patients) were included in our analysis (Fig. 1) .
Written informed consent was obtained from all patients before the procedure. The study was approved by the ethics committee of the Institutional Review Board (Institutional Review Board no. L-2017-255).
Endoscopic procedure
Diagnostic endoscopy (GIF-H260 or GIF-H290; Olympus Optical Co., Ltd., Tokyo, Japan) and endoscopic forceps biopsies were performed for all patients before ESD. Most patients were referred from other hospitals and underwent an additional biopsy or their referred biopsy specimens were reviewed again. We performed ESD using the technique previously described. [9] After creating marks 1 to 2 mm outside of the lesion, normal saline with an epinephrine and indigo carmine mixture was injected into the submucosal layer to elevate the lesion from the muscularis propria. The mucosa surrounding the lesion was then cut using an electrosurgical generator (ERBE VIO 300D, Endocut I mode, Effect 3, duration 2; Erbe Co, Tubingen, Germany) with a needle or an insulation-tipped electrosurgical knife. Finally, the connective tissue of the submucosa beneath the lesion was dissected with the coagulation current (Swift coagulation 60 W, ERBE VIO 300D). After removal of the lesions, preventive post-ESD coagulation was performed for all visibly exposed vessels (Figs. 2-4 ).
Endoscopic and pathologic evaluations
Baseline characteristics and endoscopic findings of all enrolled lesions were assessed. Endoscopic photographs and endoscopic reports were reviewed to determine the features of the lesions. A blind review was performed for all endoscopic photographs and data by 2 endoscopists (D.G. Ryu and S.J. Kim). There was agreement between the 2 regarding most lesions. When there was disagreement regarding the lesions, a diagnosis was made after further discussion. The Paris classification was used to define the gross types of superficial lesions, which were divided into elevated, flat, or depressed. [12] Central depression, surface redness, nodularity, ulceration, and submucosa fibrosis were also evaluated. Central depression was determined when the inner part of the lesion was depressed compared to its surroundings, regardless of gross type (Fig. 5A ). Surface redness was determined when there was red discoloration on the mucosal surface of the lesion compared with the surrounding mucosa (Fig. 5B) . Surface nodularity was defined as the presence of irregularly raised or nodular mucosa (Fig. 5C ). Lesions with ulcerations or scarring from previous ulceration (converging folds or deformity of the muscularis propria or fibrosis in the submucosa) were regarded as ulcerated (Fig. 5D ). If submucosa fibrosis was observed during the ESD procedure, then it was recorded with endoscopic pictures (Fig. 5E ). The lesion location was described using the Japanese Classification of Gastric Cancer. [13] Using this system, the gastric area is divided into 3 equal sections: the upper third, middle third, and lower third of the stomach.
All of the resected tissue slides were blindly reviewed by 2 pathologists. Doubtful cases were reevaluated under a multiheaded microscope to reach a consensus. The resected specimens were stretched, pinned, and fixed with formalin. Piecemealresected specimens were reconstructed as much as possible. Fixed specimens were sectioned at 2-mm intervals. The lengths of the major and minor axes were measured for all lesions. All lesions were classified as gastrointestinal epithelial neoplasia according to the Vienna classification. [8] En bloc resection was defined as resection in a one-piece manner with no residual tumor viewed endoscopically. Complete resection was defined as en bloc resection without any positive resection margins or lymphovascular invasion.
Statistical analysis
Data were analyzed based on individual lesions because some patients had multiple lesions. Univariate analysis with the chisquare test or Fisher exact test for categorical variables and Student t test for continuous variables were performed. Multivariate analysis with a multiple logistic regression model A total of 1541 lesions, contributed by 1410 patients, were included.
From December 2008 to January 2017, a total of 2011 gastric lesions was removed by endoscopic submucosal dissection.
Exclusion (n = 470)
• Early gastric cancer confirmed by endoscopic forceps biopsy prior endoscopic resection(n = 443)
• Gastric subepithelial tumor (n = 27) Figure 1 . Flow chart of the enrolled lesions in this study. ESD = endoscopic submucosal dissection.
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Medicine was performed to identify risk factors for EGC. P < .05 was considered statistically significant. Statistical calculations were performed with SPSS version 21.0 for Windows (SPSS Inc., Chicago, IL).
Results
During the study periods, a total of 1541 lesions were analyzed. The mean patient age was 63.6 ± 8.9 years. The patient population was predominantly male (71.6%; 1104/1541). The mean lesion size was 12.7 ± 8.6 mm. The main location of the lesions was the lower third of the stomach (77.5%; 1195/1541). The results of endoscopic forceps biopsy were indefinite for neoplasia (5.2%), low-grade dysplasia (71.1%), and high-grade dysplasia (23.8%). En bloc resection and complete resection rates were 97.3% (1500/1541) and 95.5% (1471/1541) ( (Table 5 and Fig. 2 ).
Discussion
Recently, ESD has been accepted as treatment for EGC without the risk of lymph node metastasis or gastric premalignant superficial neoplasia. After successful endoscopic resection, discrepant diagnoses using endoscopic forceps biopsy and ESD specimens have been clinical concerns. EGC cases with a high risk of lymph node metastasis require additional surgical gastrectomy, and patients diagnosed with EGC after endoscopic resection may be confused about future treatments. In the present study, the overall diagnostic discrepancy rate was 31.1%. The overall rate of upstaged diagnosis to EGC was 18.8%: low-grade dysplasia (6.0%), high-grade dysplasia (53.7%), and indefinite for neoplasia (33.8%). The overall rates of discrepant diagnoses were similar to those of previous studies and ranged from 20% to 40%. [14] There are a few possible reasons for discrepant diagnoses using endoscopic forceps biopsy and resected specimens. First, the adenocarcinoma lesion is too subtle to detect in a small biopsy specimen. Cancerous lesions may exist focally within background dysplastic lesions. Therefore, sampling error during an endoscopic forceps biopsy may be the major cause of diagnostic discrepancy. [9] Second, regeneration of tissue showing cellular atypia induced by active inflammation induces histologic modification, which may be associated with downstaged diagnoses after endoscopic resection. In the present study, the possible endoscopic features associated with EGC were lesion size (maximal diameter >10 mm), surface appearance (depression lesion, nodular surface, redness), and lesion location (upper third of the stomach). These results were comparable with those of previous studies. [9, 11, 15] According to the revised Vienna classification, high-grade dysplasia lesions should be resected because they are definitely premalignant or potentially malignant lesions. [8] The treatment plan is ambiguous for gastric low-grade dysplasia or indefinite for neoplasia after endoscopic forceps biopsy: do nothing if indefinite for neoplasia, endoscopic follow-up, or endoscopic resection for low-grade dysplasia. [8] However, in the present study, 33.8% of lesions indefinite for neoplasia and 6.0% of low-grade dysplasia lesions were confirmed as EGC after ESD. Therefore, it may not be appropriate to recommend regular follow-up for all these lesions. Although the natural course of gastric dysplastic lesions is not clear, reported rates of progression from dysplasia to gastric cancer vary greatly, from 0.6% to 6% per year, according to the grade of dysplasia. [16] In recent years, better en bloc resection for gastric superficial neoplasia regardless of lesion size can be achieved by ESD compared with conventional endoscopic mucosal resection using a snare. In the present study, en bloc resection and complete histologic resection rates for ESD were 97.3% and 95.5%, respectively. Therefore, gastric low-grade dysplasia and lesions indefinite for neoplasia according to endoscopic forceps biopsy that have high-risk endoscopic features of EGC should be considered for endoscopic resection, if possible, rather than regular follow-up or doing nothing.
To decrease the diagnostic discrepancy between endoscopic forceps biopsy and resected specimens, a proper endoscopic biopsy is required. An increasing number of biopsy specimens may increase the diagnostic rates. In a previous study, if 7 endoscopic forceps biopsy samples were available, then the diagnostic rate was >98% for advanced gastric cancer. [17] For gastric epithelial neoplasia before ESD, diagnostic rates of endoscopic forceps biopsy increased up to 79.1% and 83.1% after 4 endoscopic biopsies (diagnostic yield of 1 endoscopic biopsy was 65.7%-70.8%). [18] However, for gastric superficial neoplasia, especially small lesions, multiple endoscopic biopsies may be an obstacle for endoscopic resection because submucosal fibrosis is induced by endoscopic biopsy. In a previous study, the diagnostic rate of the first endoscopic biopsy was 92.3% for minute gastric cancer, but the diagnostic rates of the second biopsy were <63.6%. [19] Therefore, the first biopsy is important because bleeding in the lesion may cover the entire lesion, which may interfere with adequate tissue acquisition after the first biopsy. Theoretically, larger biopsy specimens may improve the diagnostic accuracy of gastric epithelial neoplasia. However, the diagnostic accuracy rate was not increased significantly by the use of large biopsy forceps. [18] Therefore, it is important to perform a target biopsy for the suspected EGC lesions with depression, nodular surface, and redness.
In clinical practice, proper selection of patients who need ESD is important. Therefore, characteristics of the endoscopic findings predictive of EGC are important. In the present study, risk factors associated with EGC after ESD for low-grade dysplasia were central depression, nodular surface, and surface redness. As lesions progress, structural changes appear. Central depression and nodular surface are associated with lesion progression. [20] Surface redness is associated with the development of vascular structures with disease progression. [21] In addition, larger tumor size (≥10 mm) and lesion location (upper third of the stomach) were significantly associated with upstaged diagnosis of EGC in the high-grade dysplasia group. Size is a commonly known Table 3 Characteristics and associated risk factors for upgrade diagnosis low-grade dysplasia to EGC in univariate and multivariate analysis ( * premalignant epithelial lesion, n = 1028 /EGC, n = 66). 12.6 ± 8.39 13.9 ± 7.58 * Premalignant epithelial lesion: low-grade dysplasia, high-grade dysplasia, indefinite for neoplasia. EGC = early gastric cancer; SM = submucosa; SD = standard deviation. Table 4 Characteristics and associated risk factors for upgrade diagnosis high-grade dysplasia to EGC in univariate and multivariate analysis ( * premalignant epithelial lesion, n = 170 /EGC, n = 197). Histologic comparison between endoscopic forceps biopsy and final endoscopic submucosal dissection.
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Variables
ESD Endoscopic forceps biopsy
LGD (n = 1094) HGD (n = 367) Indefinite for neoplasia (n = 80) Total (n = 1541) feature of malignancy; as the size increases, so does disease progression. [10] However, in this study, size was not significant for the low-grade dysplasia and indefinite for neoplasia groups. In clinical practice, a huge adenoma with low-grade dysplasia is sometimes seen, but the reason is unclear. Furthermore, we do not definitely know why the upper third of the stomach is a significant risk factor associated with EGC for the high-grade dysplasia group. One possible explanation is that EGC located in the lower third of the stomach, especially in the antrum, might be easily detected. To detect EGC in the upper third of the stomach, more practical experience and endoscopic procedures might be required. Therefore, EGC lesions located in the upper third of the stomach might result in delayed or missed diagnoses. Another possible explanation is that targeted biopsy of lesions located in the upper third of the stomach is difficult. Additional studies might be required to clearly explain the reasons for this finding.
There were several limitations to this study. First, it was retrospectively conducted at a single center; therefore, selection biases might be present and it is impossible to generalize the conclusions of this paper. However, we believe that this is a meaningful study because we included a large number of patients compared to other previous studies. Second, we used the conventional endoscopic appearances of lesions for the analysis. If recent diagnostic tools such as image-enhanced endoscopy were used, then more accurate diagnoses may have been made before ESD. Third, there was a possibility of discrepancy caused by performing biopsies once or twice during endoscopic resection. Multiple biopsies may result in excessive fibrosis, which is a serious problem during ESD.
In summary, when high-grade dysplasia is found by endoscopic forceps biopsy, ESD should be considered. Low-grade dysplasia lesions with central depression, nodular surface, and surface redness and lesions that are indefinite for neoplasia with depression and surface redness should also be considered for ESD. Furthermore, lesions with these risk factors should be examined for the possibility of gastric cancer and the possibility for surgery before endoscopic resection. Table 5 Characteristics and associated risk factors for upgrade diagnosis indefinite neoplasia to EGC in univariate and multivariate analysis ( * premalignant epithelial lesion, n = 53 /EGC, n = 27).
Variables
Premalignant epithelial lesion, n (%) EGC, n (%) 
